Literature DB >> 21159635

Conditional deletion of the focal adhesion kinase FAK alters remodeling of the blood-brain barrier in glioma.

Jisook Lee1, Alexandra K Borboa, Hyun Bae Chun, Andrew Baird, Brian P Eliceiri.   

Abstract

Gliomas generally infiltrate the surrounding normal brain parenchyma, a process associated with increased vascular permeability (VP) and dysregulation of the blood-brain barrier (BBB). However, the molecular mechanisms underlying glioma-induced VP in the brain remain poorly understood. Using a conditional, endothelium-specific deletion of the focal adhesion kinase (FAK) in the mouse (FAK CKO), we show that FAK is critical for destabilization of the tumor endothelium in tumor-bearing mice, with mutant mice exhibiting a relatively normalized vasculature compared with wild-type mice (FAK WT). Tumor vessels in the FAK CKO mice displayed reduced VP compared with FAK WT mice, resulting in reduced tumor growth. Additionally, FAK CKO mice displayed partial restoration of cell-cell junction proteins in the tumor vessels and astrocyte-endothelium interactions in tumors, revealing an additional role of astrocytes in mediating tumor-induced VP. Together, these results provide genetic evidence that FAK is a mediator of tumor-induced VP in the brain. Our findings may help understand how therapeutics might be used to regulate specific cell-type interactions to restore BBB structure/function in cancer and perhaps other pathologic conditions. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21159635      PMCID: PMC3059220          DOI: 10.1158/0008-5472.CAN-10-2740

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

Review 1.  Focal adhesion kinase: in command and control of cell motility.

Authors:  Satyajit K Mitra; Daniel A Hanson; David D Schlaepfer
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

2.  Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.

Authors:  E A Neuwelt; S I Rapoport
Journal:  Fed Proc       Date:  1984-02

3.  Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses.

Authors:  C A Kruse; D H Mitchell; B K Kleinschmidt-DeMasters; W A Franklin; H G Morse; E B Spector; K O Lillehei
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

4.  Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae.

Authors:  Arne Warth; Stephan Kröger; Hartwig Wolburg
Journal:  Acta Neuropathol       Date:  2004-01-20       Impact factor: 17.088

5.  Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.

Authors:  Darlene E Jenkins; Yoko Oei; Yvette S Hornig; Shang-Fan Yu; Joan Dusich; Tony Purchio; Pamela R Contag
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration.

Authors:  D J Sieg; D Ilić; K C Jones; C H Damsky; T Hunter; D D Schlaepfer
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

7.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice.

Authors:  D Ilić; Y Furuta; S Kanazawa; N Takeda; K Sobue; N Nakatsuji; S Nomura; J Fujimoto; M Okada; T Yamamoto
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

8.  FAK deficiency in cells contributing to the basal lamina results in cortical abnormalities resembling congenital muscular dystrophies.

Authors:  Hilary E Beggs; Dorreyah Schahin-Reed; Keling Zang; Sandra Goebbels; Klaus Armin Nave; Jessica Gorski; Kevin R Jones; David Sretavan; Louis F Reichardt
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

9.  Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden.

Authors:  Zain Paroo; Robert A Bollinger; Dwaine A Braasch; Edmond Richer; David R Corey; Peter P Antich; Ralph P Mason
Journal:  Mol Imaging       Date:  2004-04       Impact factor: 4.488

Review 10.  Focal adhesion kinase: at the crossroads of signal transduction.

Authors:  D Ilić; C H Damsky; T Yamamoto
Journal:  J Cell Sci       Date:  1997-02       Impact factor: 5.285

View more
  26 in total

1.  Ghrelin prevents disruption of the blood-brain barrier after traumatic brain injury.

Authors:  Nicole E Lopez; Michael J Krzyzaniak; Chelsea Blow; James Putnam; Yan Ortiz-Pomales; Ann-Marie Hageny; Brian Eliceiri; Raul Coimbra; Vishal Bansal
Journal:  J Neurotrauma       Date:  2011-10-26       Impact factor: 5.269

2.  VEGF-induced vascular permeability is mediated by FAK.

Authors:  Xiao Lei Chen; Ju-Ock Nam; Christine Jean; Christine Lawson; Colin T Walsh; Erik Goka; Ssang-Taek Lim; Alok Tomar; Isabelle Tancioni; Sean Uryu; Jun-Lin Guan; Lisette M Acevedo; Sara M Weis; David A Cheresh; David D Schlaepfer
Journal:  Dev Cell       Date:  2012-01-17       Impact factor: 12.270

Review 3.  Endothelial FAK as a therapeutic target in disease.

Authors:  Giovanni A Infusino; Jeffrey R Jacobson
Journal:  Microvasc Res       Date:  2011-10-06       Impact factor: 3.514

Review 4.  Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability.

Authors:  Yulia A Komarova; Kevin Kruse; Dolly Mehta; Asrar B Malik
Journal:  Circ Res       Date:  2017-01-06       Impact factor: 17.367

5.  Neutrophil-Derived Reactive Oxygen Orchestrates Epithelial Cell Signaling Events during Intestinal Repair.

Authors:  Jason D Matthews; Joshua A Owens; Crystal R Naudin; Bejan J Saeedi; Ashfaqul Alam; April R Reedy; Benjamin H Hinrichs; Ronen Sumagin; Andrew S Neish; Rheinallt M Jones
Journal:  Am J Pathol       Date:  2019-08-28       Impact factor: 4.307

6.  Non-invasive detection of spatio-temporal activation of SBE and NFAT5 promoters in transgenic reporter mice following stroke.

Authors:  Ashkaun Shaterian; Alexandra Borboa; Raul Coimbra; Andrew Baird; Brian P Eliceiri
Journal:  Neuropathology       Date:  2011-07-12       Impact factor: 1.906

7.  Prognostic significance of c-Met, β-catenin and FAK in patients with hepatocellular carcinoma following surgery.

Authors:  Xue-Yi Gong; Ning Ma; Hong-Xu Xu; Fan Chen; Xiao-Hui Huang; Qian Wang
Journal:  Oncol Lett       Date:  2018-01-05       Impact factor: 2.967

Review 8.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

9.  Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide.

Authors:  Vita M Golubovskaya; Grace Huang; Baotran Ho; Michael Yemma; Carl D Morrison; Jisook Lee; Brian P Eliceiri; William G Cance
Journal:  Mol Cancer Ther       Date:  2012-12-12       Impact factor: 6.261

10.  Magnetic targeting of nanoparticles across the intact blood-brain barrier.

Authors:  Seong Deok Kong; Jisook Lee; Srinivasan Ramachandran; Brian P Eliceiri; Veronica I Shubayev; Ratnesh Lal; Sungho Jin
Journal:  J Control Release       Date:  2012-10-10       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.